FDA issues draft guidance for AI-enabled devices
(By Alexandra Murphy for Becker’s Hospital Review) The FDA has released draft guidance for developers of AI-enabled medical devices, offering
Read More
FDA
FDA approves GLP-1 generic
(By Paige Twenter for Becker’s Hospital Review) On Dec. 23, the FDA approved Hikma Pharmaceuticals’ liraglutide injection, a generic version
Read MoreFDA approves weight loss drug Zepbound to treat obstructive sleep apnea
(By Juliana Kim for NPR) The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive
Read MoreFlorida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval
(By Phil Galewitz for KFF Health News) Nearly a year after the Biden administration gave Florida the green light to
Read MoreFDA adds warning to Ozempic, Mounjaro and other GLP-1 labels
(By Alexandra Murphy for Becker’s Hospital Review) The FDA has updated the labels for all GLP-1 receptor agonists, including popular
Read MoreWhy hospitals still can’t get the supplies they need
(By Stefanie Asin for Becker’s Hospital Review) During the COVID-19 pandemic, healthcare supply chain issues were complex and plentiful, creating
Read MoreOptum joins CVS, Cigna in dropping Humira
(By Rylee Wilson for Becker’s Hospital Review) Optum Rx will join the other major pharmacy benefit managers and exclude Humira
Read MoreWith TV Drug Ads, What You See Is Not Necessarily What You Get
(By Elisabeth Rosenthal for KFF Health News) Triumphant music plays as cancer patients go camping, do some gardening, and watch
Read More6 drugs now in shortage
(By Paige Twenter for Becker’s Hospital Review) The sole suppliers for a few medications, including a Parkinson’s disease therapy, are
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More